Chris Bahl

Chris Bahl has an impressive background in biochemistry and protein design, holding various leadership and advisory positions in multiple companies and organizations. Currently, Chris serves as the President, Chief Scientific Officer, and Co-Founder of AI Proteins, while also being a Scientific Advisor at BioLoomics, Inc. and Applied Photophysics. Additionally, Chris is associated with Boston Children's Hospital and Harvard Medical School in scientific research and lecturing roles. With a PhD in Biochemistry from Geisel School of Medicine at Dartmouth, Chris has a wealth of knowledge and experience in the field.